1. Prevention by (±)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol;Andersen;Br. J. Pharmacol.,1996
2. Aripiprazole is a high affinity partial agonist at human D2 dopamine receptors;Burris;Int. J. Neuropsychopharmacol.,2000
3. Activity of aripiprazole in psychotic disorders: comparison with haloperidol and placebo;Carson;Eur. Neuropsychopharmacol.,2000
4. Effects of the novel antipsychotic agent 7-(4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597) on prolactin release from the rat anterior pituitary gland;Inoue;J. Pharmacol. Exp. Ther.,1996
5. In vivo effects of aripiprazole on dopaminergic and serotonergic function in rat prefrontal cortex and striatum;Jordan;Soc. Neurosci. Abstr.,2001